journal
Journals Australasian Journal of Dermat...

Australasian Journal of Dermatology

https://read.qxmd.com/read/37002720/febrile-ulceronecrotic-mucha-habermann-disease-during-pregnancy-a-case-report
#1
JOURNAL ARTICLE
Ceylan Avcı, Özlem Gürbüz, Özlem Özbağçıvan, Banu Lebe
Febrile ulceronecrotic Mucha-Habermann disease (FUMHD) is a rare and severe form of 'pityriasis lichenoides et varioliformis acuta', with a progressive and potentially fatal course. To the best of our knowledge, there has been no reported case of FUMDH during pregnancy before. Due to life-threatening nature of the disease and the lack of evidence-based treatment, management of FUMHD in pregnancy is a therapeutic challenge. Additionally, some of the drugs that are effective in the treatment are contraindicated in pregnancy...
April 1, 2023: Australasian Journal of Dermatology
https://read.qxmd.com/read/37002712/stage-ia-melanoma-follow-up-exploring-the-level-of-confidence-of-south-australian-general-practitioners-in-undertaking-surveillance-skin-checks-including-considerations-for-shared-care
#2
JOURNAL ARTICLE
Thomas Mathew, Damian J Ianno, Shireen K Sidhu
BACKGROUND: The literature highlights the role of Australian general practitioners (GP) in the management of skin cancers. With melanoma incidences on the rise, there have been discussions into whether lower-risk stage IA patients could safely be followed up by their GPs for annual surveillance full skin examinations (FSE). This study explores the level of confidence of South Australian (SA) GPs in undertaking FSEs including factors that could support discussions around shared care between GPs and dermatology units for lower-risk patients...
April 1, 2023: Australasian Journal of Dermatology
https://read.qxmd.com/read/36971373/academic-dermatology-in-australia-and-new-zealand-between-2017-and-2022-a-cross-sectional-bibliometric-analysis
#3
JOURNAL ARTICLE
James P Pham, Anes Yang, John W Frew
INTRODUCTION: Academic dermatologists in Australia and New Zealand provide high-quality and meaningful contributions to the understanding of disease and therapeutic translational research. Concerns have been raised by the Australian Medical Association regarding the decline of clinical academics in Australia as a whole, however, such trends in scholarly output have not previously been analysed for Australasian dermatologists. METHODS: A bibliometric analysis of dermatologists in Australia and New Zealand was conducted in January and February 2023...
March 27, 2023: Australasian Journal of Dermatology
https://read.qxmd.com/read/36961092/intravenous-immunoglobulin-treatment-for-refractory-pyoderma-gangrenosum
#4
JOURNAL ARTICLE
Jacqueline K Nguyen, Zachary Holmes, Robert I Kelly
BACKGROUND: Intravenous immunoglobulins (IVIG) have been increasingly used for various inflammatory dermatoses with success. Small case series and case reports suggest a role for IVIG in the management of refractory pyoderma gangrenosum (PG). OBJECTIVE: The objective was to study the characteristics of PG patients treated with IVIG and the efficacy and safety of IVIG for patients with refractory PG. METHODS: An analysis was performed of all patients with PG treated with IVIG from 2012 to 2022 at an Australian tertiary hospital seeing a high volume of PG patients...
March 24, 2023: Australasian Journal of Dermatology
https://read.qxmd.com/read/36960976/measuring-the-quality-of-skin-cancer-management-in-primary-care-a-scoping-review
#5
REVIEW
Samantha Spanos, Nehal Singh, Bela I Laginha, Gaston Arnolda, David Wilkinson, Andrea L Smith, Anne E Cust, Jeffrey Braithwaite, Frances Rapport
Skin cancer is a growing global problem and a significant health and economic burden. Despite the practical necessity for skin cancer to be managed in primary care settings, little is known about how quality of care is or should be measured in this setting. This scoping review aimed to capture the breadth and range of contemporary evidence related to the measurement of quality in skin cancer management in primary care settings. Six databases were searched for relevant texts reporting on quality measurement in primary care skin cancer management...
March 24, 2023: Australasian Journal of Dermatology
https://read.qxmd.com/read/36920437/porokeratotic-lichen-planus-of-the-lower-extremities
#6
LETTER
Jiandan Li, Xiaojing Liu, Qian Du, Xiuli Wang, Peiru Wang
No abstract text is available yet for this article.
March 15, 2023: Australasian Journal of Dermatology
https://read.qxmd.com/read/36912730/demography-baseline-disease-characteristics-and-treatment%C3%A2-history-of-patients-with-psoriasis-in-the-philippines-a-multicenter-retrospective-study
#7
JOURNAL ARTICLE
Bryan Edgar K Guevara, Lily Lyralin Tumalad, Emmerson Gale Vista, Jennifer Lavina Ngo, Frances Beatrice Alarilla, Roel F Ceballos, Mark Jayson Malaluan, Bai Shariffah Pandita-Reyes
No abstract text is available yet for this article.
March 13, 2023: Australasian Journal of Dermatology
https://read.qxmd.com/read/36896913/therapeutic-effect-of-intralesional-1-sodium-tetradecyl-sulphate-injection-for-digital-mucous-cysts
#8
JOURNAL ARTICLE
Eun Ji Chun, Hyun Chul Chung, Joon Ki Kim, Sang Seok Kim, Chul Woo Kim
No abstract text is available yet for this article.
March 10, 2023: Australasian Journal of Dermatology
https://read.qxmd.com/read/36896897/mogamulizumab-associated-rash-a-challenging-case-report-and-literature-review
#9
Sandra Martínez-Fernández, Hae-Jin Suh-Oh, Carmen Couselo-Rodríguez, Diego Soto-García, Carlos Álvarez, Ángeles Flórez
No abstract text is available yet for this article.
March 10, 2023: Australasian Journal of Dermatology
https://read.qxmd.com/read/36892928/cd30-positive-lymphoproliferative-disorders-an-australian-clinical-practice-statement-from-the-peter-maccallum-cancer-centre
#10
REVIEW
Friyana K Bhabha, Christopher McCormack, Belinda A Campbell, Stephen Lade, Odette Buelens, Carrie Van Der Weyden, H Miles Prince
The CD30-postive lymphoproliferative disorders, including lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma, account for up to 30% of all cutaneous T-cell lymphomas (CTCLs) and are the second most common form of CTCLs after mycosis fungoides. Both conditions differ in their clinical presentations; however, they share the expression of the CD30 antigen as a common immunophenotypic hallmark. There is a wide spectrum of management options depending on factors such as extent of disease, staging and treatment tolerability...
March 9, 2023: Australasian Journal of Dermatology
https://read.qxmd.com/read/36892905/proximal-type-vulvar-epithelioid-sarcoma-masquerading-as-cellulitis-in-a-young-female
#11
Takako Miura, Nobuyuki Kikuchi, Hitoshi Yamada, Michiyuki Hakozaki, Takahiro Tajino, Mikio Ohtsuka, Toshiyuki Yamamoto
No abstract text is available yet for this article.
March 9, 2023: Australasian Journal of Dermatology
https://read.qxmd.com/read/36866918/omalizumab-treatment-in-combination-with-any-other-biologics-is-it-really-a-safe-duo
#12
JOURNAL ARTICLE
Sema Koç Yıldırım, Ece Erbağcı, Aslı Hapa
BACKGROUND: Chronic spontaneous urticaria (CSU) is a mast cell-mediated disease, which is sometimes associated with various inflammatory disorders. Omalizumab is a commonly used biological agent, which is a recombinant, humanized, monoclonal antibody against human immunoglobulin E. However, there are only few reports about the combination of omalizumab for CSU with any other biologics for accompanying inflammatory diseases in the literature. The aim of this study was to evaluate the patients whose treatment of omalizumab for CSU were combined with any other biologics for associated inflammatory disorders and to describe whether these combinations might have any safety concerns...
March 3, 2023: Australasian Journal of Dermatology
https://read.qxmd.com/read/36866916/a-novel-xpa-splice-site-mutation-identified-in-a-4-year-old-filipino-girl-with-xeroderma-pigmentosum
#13
JOURNAL ARTICLE
Haider H Reyes, Yu-Chen Lin, Chao-Kai Hsu, Bryan Edgar K Guevara
We herein report a case of a 4-year-old Filipino girl initially seen through online consultation from a general physician. She was born to a 22-year-old primigravid mother, with no birth complications nor a history of consanguinity in the family. During the 1st month of life, she developed hyperpigmented macules over the face, neck, upper back, and limbs, which were exacerbated by sun exposure. At 2 years old, she developed a solitary erythematous papule on the nasal area, which gradually enlarged within one year and developed into an exophytic ulcerating tumor extending to the right supra-alar crease (Figure 1a,b)...
March 3, 2023: Australasian Journal of Dermatology
https://read.qxmd.com/read/36843046/semi-automated-total-body-photography-can-identify-subtle-melanomas-but-false-negatives-on-automated-comparison-highlight-the-need-for-manual-side-by-side-image-comparison
#14
Mohsen Hassani, Christine Lee, Aksana Marozava, Nikita Rosendahl, Blake O'Brien, Sarah Wallace, Cliff Rosendahl
No abstract text is available yet for this article.
February 26, 2023: Australasian Journal of Dermatology
https://read.qxmd.com/read/36840895/a-sheep-in-wolf-s-clothing-agminated-blue-naevi-masquerading-as-in-transit-melanoma-metastases
#15
LETTER
Nicholas C Allen, Elizabeth C Paver, Nita Agar, Richard A Scolyer, Fergal J Moloney
No abstract text is available yet for this article.
February 25, 2023: Australasian Journal of Dermatology
https://read.qxmd.com/read/36825822/sufu-associated-gorlin-syndrome-expanding-the-spectrum-between-classic-nevoid-basal-cell-carcinoma-syndrome-and-multiple-hereditary-infundibulocystic-basal-cell-carcinoma
#16
JOURNAL ARTICLE
Marcial Álvarez-Salafranca, Mar García-García, Andrea Montes-Torres, Ignacio Rivera-Fuertes, María Teresa López-Giménez, Mariano Ara
Basal cell nevus syndrome (BCNS), also known as Gorlin syndrome, is characterized by an aberrant activation of the hedgehog (Hh) pathway, most cases being caused by PTCH1 mutations. However, certain features such as multiple hereditary infundibulocystic basal cell carcinomas (MHIBCC), sclerotic fibromas, childhood medulloblastoma or meningioma may be relatively specific to a SUFU mutation. We present two patients with MHIBCC, along with a more complex cutaneous and extracutaneous phenotype. MHIBCC syndrome and BCNS may share clinical features and, indeed, both syndromes probably represent different degrees of upregulation in the Hh pathway...
February 24, 2023: Australasian Journal of Dermatology
https://read.qxmd.com/read/36825814/primary-cutaneous-amyloidosis-a-review-of-the-available-studies-and-gaps-in-data
#17
REVIEW
Tim Aung, Rowland Noakes, Dedee F Murrell, Benjamin S Daniel, Awatef Kelati
No abstract text is available yet for this article.
February 24, 2023: Australasian Journal of Dermatology
https://read.qxmd.com/read/36810977/myopericytomatosis-a-rare-entity-mimicking-other-vascular-tumours-and-malformations
#18
JOURNAL ARTICLE
Lois Zhang, Mina Kang, Steven Kossard, Kurosh Parsi
Myopericytoma is a rare tumour which typically presents as a benign lesion that mimics features of other more common vascular tumours and malformations. We present a case of a symptomatic diffuse myopericytomatosis of the left abdomen presenting as multiple subcutaneous vascular tumours detected on ultrasound and treated with ultrasound-guided sclerotherapy.
February 22, 2023: Australasian Journal of Dermatology
https://read.qxmd.com/read/36810815/a-review-of-jak-and-il-23-inhibitors-to-treat-vitiligo
#19
REVIEW
Henry Lee, Timothy L Cowan, Benjamin S Daniel, Dédée F Murrell
Vitiligo is an autoimmune skin disorder resulting in the depigmentation of skin characterised by patches of varying sizes and shapes. A common disorder of pigmentation that affects 0.5%-2% of the global population. Despite its well-understood autoimmune pathogenesis, the targets for effective cytokine intervention remain unclear. Current first-line treatments include oral or topical corticosteroids, calcineurin inhibitors and phototherapy. These treatments are limited, have varying efficacies, and are associated with significant adverse events or can be time-consuming...
February 22, 2023: Australasian Journal of Dermatology
https://read.qxmd.com/read/36808729/pirfenidone-induced-photolichenoid-drug-eruption
#20
Nikhil Dwivedi, Jessica Witherspoon, Simon Yong-Gee
No abstract text is available yet for this article.
February 20, 2023: Australasian Journal of Dermatology
journal
journal
21819
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.